Downloads
Title
Source name
Date

Biocon Biologics Limited - 7/26/2024

Biocon Biologics Limited - 7/26/2024

FDA orangebook
06 Sep 2024

FDA warns consumers not to purchase or use Umary and Amazy products as they may be harmful to your health

FDA is warning consumers not to purchase or use Umary and Amazy products, marketed as dietary supplements, as they may be harmful to your health. This is due to potentially dangerous hidden drug ingre

FDA orangebook
06 Sep 2024

FDA warns consumers not to purchase or use Umary and Amazy products as they may be harmful to your health

FDA is warning consumers not to purchase or use Umary and Amazy products, marketed as dietary supplements, as they may be harmful to your health. This is due to potentially dangerous hidden drug ingre

FDA orangebook
06 Sep 2024

New Drugs Regulatory Program Modernization: Integrated Assessment of Marketing Applications and Integrated Review Documentation

View details about the NDRP Modernization: Integrated Assessment of Marketing Applications and Integrated Review Documentation; Request for comments

FDA orangebook
06 Sep 2024

New Drugs Regulatory Program Modernization: Integrated Assessment of Marketing Applications and Integrated Review Documentation

View details about the NDRP Modernization: Integrated Assessment of Marketing Applications and Integrated Review Documentation; Request for comments

FDA orangebook
06 Sep 2024

Youth E-Cigarette Use Drops to Lowest Level in a Decade

Today, the FDA and CDC released new data from the National Youth Tobacco Survey, including findings on e-cigarette and nicotine pouch use among U.S. youth

FDA orangebook
06 Sep 2024

September 5, 2024

Today, the FDA and CDC released new data from the National Youth Tobacco Survey, including findings on e-cigarette and nicotine pouch use among U.S. youth

FDA orangebook
06 Sep 2024

Ventilator Correction: Breas Medical Updates Use Instructions for Vivo 45 LS due to Potential Elevated Formaldehyde Levels in Newly Manufactured Ventilators

Vivo 45 LS ventilators support breathing in homes and health settings. New devices may expose users to elevated formaldehyde levels for a short time.

FDA orangebook
05 Sep 2024

Continuous Glucose Monitoring (CGM) Sensor Recall: Abbott Diabetes Care Inc Issues Recall for Certain FreeStyle Libre 3 Sensors due to Risk for Inaccurate High Glucose Readings

FreeStyle Libre 3 sensor provides continuous monitoring of glucose levels but a small number of sensors may give inaccurate high readings

FDA orangebook
05 Sep 2024

Laryngoscope Recall: Medtronic Removes Certain McGrath MAC Video Laryngoscopes, Updates Use Instructions for Others due to Increased Risk for Battery Overheat and Explosion

McGrath MAC Video Laryngoscopes help visualize the trachea and larynx. The batteries on these devices may deplete too much, causing overheating and explosion.

FDA orangebook
05 Sep 2024

Direct Final Rule Procedures

Guidance for FDA and Industry - Direct Final Rule Procedures

FDA orangebook
05 Sep 2024

Compliance Policy Guides Index

Compliance Policy Guides Index

FDA orangebook
05 Sep 2024

CDER Nitrosamine Impurity Acceptable Intake Limits

Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs); Updated Information

FDA orangebook
05 Sep 2024

Smiths Medical Issues Urgent Medical Device Notification Informing Customers of a Potential Issue with Certain Bivona® Tracheostomy Tubes

Smiths Medical issued an Urgent Medical Device Notification on May 29, 2024, to notify affected customers of a potential issue with certain Bivona® Tracheostomy Tubes

FDA orangebook
05 Sep 2024

Lung Therapy Component Recall: Baxter Healthcare Corporation Recalls Certain Volara System Single-Patient Use Circuits and Blue Ventilator Adapter Assemblies Due to Disconnection Risk That May Prevent Proper Ventilation

The Volara System provides lung therapy for patients on ventilators but some single-patient use circuits and blue ventilator adapter assemblies may disconnect.

FDA orangebook
04 Sep 2024

Mother Stem Institute, Corp. - 680118 - 08/20/2024

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

FDA orangebook
04 Sep 2024

Prescriber Perceptions of Boxed Warnings: A Qualitative study

CDER research finds that boxed warnings are only one of several factors that influence prescriber treatment decisions.

FDA orangebook
04 Sep 2024

Transcript: Angiotensin II Receptor Blockers (ARBs) - A Message for Patients

Transcript: Angiotensin II Receptor Blockers (ARBs) - A Message for Patients

FDA orangebook
04 Sep 2024

Kaylaan LLC - 681977 - 08/19/2024

CGMP/Finished Pharmaceuticals/Adulterated

FDA orangebook
04 Sep 2024

Everymarket Inc. - 688348 - 08/27/2024

Unapproved New Drugs/Misbranded

FDA orangebook
04 Sep 2024

SoloVital - 688046 - 08/27/2024

Unapproved New Drugs/Misbranded

FDA orangebook
04 Sep 2024
FDA orangebook
04 Sep 2024

La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente

La FDA autorizó para uso de emergencia la vacuna contra el COVID-19 de Novavax actualizada (fórmula 2024-2025) con el fin de atacar más de cerca las variantes que circulan actualmente y brindar una me

FDA orangebook
04 Sep 2024

Oncologic Drugs Advisory Committee Charter

This is the Charter for the Oncologic Drugs Advisory Committee.

FDA orangebook
02 Sep 2024
We use cookies to enhance your browsing experience. By continuing to use our website you agree to our policies Read the policyAccept